http://www.imim.cat/noticies Programa de recerca: Càncer http://www.imim.cat/noticies/view.php?ID=736 <p>The journal Cancer Cell has published a study led by the Hospital del Mar Research Institute, together with researchers from GEICAM, identifying malignant cells carrying the TIM-3 protein as a central factor in their ability to generate breast cancer metastasis.</p> <p>This molecule allows cancer cells to survive the most critical and challenging stage of metastasis-when they first reach a new organ-by evading immune system attacks. At the same time, it may serve as a marker of poor prognosis and metastasis risk in patients with TIM-3-positive tumors.</p> <p>This discovery opens the door to the potential use of treatments that block TIM-3 to prevent metastasis before it becomes clinically evident.</p> 10/07/2025